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SHORT COMMUNICATION
Annexin VI has tumour-suppressor activity in human A431 squamous
epithelial carcinoma cells
J Theobald', A Hanby2, K Patel2 and SE Moss'
'Department ofPhysiology, University College London, Gower Street, London WCIE 6BT, UK; 2Histopathology Unit, Imperial
Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PN, UK.
Summary In this study we show that heterologous expression of annexin VI in A431 squamous carcinoma
cells caused a marked suppression of tumour cell growth when cells were cultured subcutaneously in nude
mice. The tumours formed by the annexin VI' A431 cells were morphologically and histologically similar to
those formed by the wild-type cells.
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Annexin VI is one of a large family of calcium-dependent
phospholipid-binding proteins and is expressed in many cells
and tissues throughout multicellular eukaryotic phyla
(Raynal and Pollard, 1994; Smith and Moss, 1994). Members
of the annexin family have been implicated in a variety of
important physiological processes, including exocytosis and
endocytosis, anti-inflammation, anti-coagulation and calcium
channel activity. Annexin VI has been demonstrated to in-
crease the mean open time of the sarcoplasmic reticulum
calcium channel (Diaz-Munoz et al., 1989), to be an inhibitor
of protein kinase C (Shibata et al., 1989) and to be required
for budding of clathrin-coated pits in vitro (Lin et al., 1992)
but not in vivo (Smythe et al., 1994). Little is known about
the in vivo function of annexin VI, although evidence exists
to support a role for annexin VI in aspects of cell growth
regulation. First, annexin VI is subject to growth-dependent
post-translational modification in cells as diverse as murine
Swiss 3T3 fibroblasts and human T lymphoblasts (Moss et
al., 1990). Second, annexin VI has been shown to reduce the
rate of proliferation of A431 cells in culture, in a serum
concentration-dependent manner (Theobald et al., 1994). We
now report that the growth-suppressive effect of annexin VI
extends to tumour suppression and suggest that annexin VI
expression may be a critical determinant of tumour growth
rate.
Materials and methods
A431 cells
Human A431 cells and clonal variants expressing annexin VI
have been described previously (Theobald et al., 1994). For
analysis of tumour growth, four clones were used, namely C7
and C8, which were transfected with the plasmid pRC.CMV
(Invitrogen) and do not express annexin VI, and C3 and CK,
which were transfected with the same plasmid containing the
human annexin VI cDNA and which express annexin VI at
physiological levels (Theobald et al., 1994).
Tumour growth in nude mice
Nude mice were injected subcutaneously on the flanks with
107 A431 cells. In some cases both flanks were used, giving
totals of 15 and 17 sites for the control and test groups
respectively. Each group comprised ten mice. Nine days after
injection the tumours were excised and weighed.
Histological analysis oftumours
Tissue from each tumour was fixed in neutral-buffered for-
malin (NBF), processed and embedded in paraffin wax from
which serial 4 pm sections were cut. Sections from each
tumour were stained with haematoxylin and eosin (H&E) to
allow morphological assessment and parallel sections to these
stained with a polyclonal antibody to annexin VI (see below).
Assessment of a number of histological features was per-
formed by a pathologist unaware of which tumour belonged
to which group. The features assessed were tumour cyto-
morphology, amount/number of giant cells, necrosis, apop-
tosis, tumour cell palisading, inflammation and tumour
vascularity and were scored 0-3 (absent to abundant). The
overall appearance of the tumours was also assessed.
Immunohistochemical staining
Sections from all the tumours were stained with the MC2
rabbit polyclonal anti-annexin VI serum (immunoglobulin G
fraction), which has been extensively described (Crompton et
al., 1988; Clark et al., 1991; Moss et al., 1992). Before
incubation with anti-annexin VI (1:100), sections were micro-
waved in 0.1 M sodium citrate for Omin and then a standard
streptavidin-biotin complex (SABC) immunohistochemical
technique was employed, with development of the colour
reaction using diaminobenzidine (DAB). As with the mor-
phological interpretation the sections were assessed 'blind' by
a histopathologist.
Results
To determine whether growth inhibition observed in annexin
VI' A431 cells in culture extended to tumour growth sup-
pression in nude mice, animals were injected with aliquots of
control and annexin VI' cells and tumour growth monitored.
For both sets of cell types, tumours appeared within a few
days and grew rapidly over a period of 2 weeks before
excision. The mean tumour masses for the two groups are
shown in Figure 1. The tumours formed by the control cells
were on average >60% larger than those formed by the
annexin VI' cells (P<0.05 by Student's t-test). To confirm
that tumours were derived from the cells that had been
injected, sections taken from paraffin-embedded tissue were
stained for annexin VI (Figure 2). In all tumours examined,
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Figure 1 Tumour sizes from control and annexin VI' groups.
Mean tumour masses with standard error bars are shown for
control (U, n = 15) and annexin VI' (0, n = 17) groups.
those from the control group failed to stain for annexin VI,
whereas those transfected with annexin VI exhibited strong
but diffuse cytoplasmic staining, similar to the staining char-
acteristics of annexin VI in normal human tissues (Clark et
al., 1991). Histological examination failed to reveal any
significant difference between the features of the control
group and the experimental group either overall or in any of
the specific features detailed earlier.
Discussion
Human A431 squamous carcinoma epithelial cells have been
extensively used in the st,udy of both signal transduction via
the epidermal growth factor receptor and endocytosis via the
transferrin receptor. Recently, we showed that these cells do
not express annexin VI (Smythe et al., 1994). We also made
the unexpected observation that heterologous expression of
annexin VI in these cells causes a moderation of proliferative
rate at low serum concentrations (Theobald et al., 1994). The
reduced proliferative rate could not have been due to in-
creased biosynthetic burden since A431 cells overexpressing
annexin VI had normal growth characteristics or related to
plasmid copy number since C7, C8 and CK were virtually
indistinguishable by Southern blot analysis of the neomycin
gene, while C3 had reduced levels (unpublished observa-
tions). To determine whether or not the growth-inhibitory
effect of annexin VI is of genuine physiological significance
or restricted to conditions of cell culture, we investigated the
ability of control and annexin VI' A431 cells to form
tumours in nude mice.
The results show that, although both groups still consist of
highly malignant and morphologically similar neoplasms, ex-
pression of annexin VI in A431 cells is clearly associated with
diminished tumour growth rate and sijggest a function for
annexin VI in cell growth regulation. Further examination is
required to investigate the mechanism of the growth-retard-
ing effect of annexin VI expression; for example, is it slowing
down the cell cycle or does it enhance cell death? Previous
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Figure 2 Immunohistochemical staining of annexin VI in
tumours. (a) Tumours derived from control A431 cells fail to
stain for annexin VI whereas (b) tumours derived from annexin
VI+ A431 cells exhibit strong but variable cytoplasmic staining
with antibody MC2. Control (c) shows an annexin VI+ tumour
stained with preimmune serum derived from the same rabbit as
the antibody MC2.
data suggest that the effect may be related to increased
cell-cell contact-mediated growth inhibition (Theobald et al.,
1994).
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